UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium

Circulation (New York, N.Y.), 2010-03, Vol.121 (12), p.1382-1392

2010

Volltextzugriff (PDF)

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

Annals of internal medicine, 1991-08, Vol.115 (4), p.256-265

1991

Volltextzugriff (PDF)

Inherited predisposition to thrombosis

Cell, 1993-02, Vol.72 (4), p.477-480

1993

Volltextzugriff (PDF)

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

Arteriosclerosis, thrombosis, and vascular biology, 1997-10, Vol.17 (10), p.2167-2176

1997

Volltextzugriff (PDF)

Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers: Evidence from Atomic Force Microscopy and Functional Assay

The American journal of pathology, 2003-09, Vol.163 (3), p.1193-1200

2003

Volltextzugriff (PDF)

Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study

Journal of thrombosis and haemostasis, 2010-08, Vol.8 (8), p.1730-1735

2010

Volltextzugriff (PDF)

Laboratory methods and quality assurance in the Cardiovascular Health Study

Clinical chemistry (Baltimore, Md.), 1995-02, Vol.41 (2), p.264-270

1995

Volltextzugriff (PDF)

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)

The American journal of cardiology, 1997-02, Vol.79 (4), p.391-396

1997

Volltextzugriff (PDF)

Markers of thrombin and platelet activity in patients with Atrial Fibrillation: Correlation with Stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III study

Stroke (1970), 1999-12, Vol.30 (12), p.2547-2553

1999

Volltextzugriff (PDF)

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C‐deficient family

Journal of thrombosis and haemostasis, 2004-02, Vol.2 (2), p.242-247

2004

Volltextzugriff (PDF)

The impact of venous thrombosis on quality of life

Thrombosis research, 2004, Vol.114 (1), p.11-18

2004

Volltextzugriff (PDF)

A review of the technical, diagnostic, and epidemiologic considerations for protein S assays

Archives of pathology & laboratory medicine (1976), 2002-11, Vol.126 (11), p.1349-1366

2002

Volltextzugriff (PDF)

The Clinical Spectrum of Heterozygous Protein C Deficiency in a Large New England Kindred

Blood, 1989-02, Vol.73 (3), p.712-717

1989

Volltextzugriff (PDF)

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial

Journal of thrombosis and haemostasis, 2005-03, Vol.3 (3), p.439-447

2005

Volltextzugriff (PDF)

Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial

British journal of haematology, 2003-01, Vol.120 (1), p.109-116

2003

Volltextzugriff (PDF)

Vitamin K and oral anticoagulation: thought for food

The American journal of medicine, 2004-05, Vol.116 (10), p.711-713

2004

Volltextzugriff (PDF)

Evaluating chronic venous disease with a new venous severity scoring system

Journal of vascular surgery, 2003-11, Vol.38 (5), p.909-915

2003

Volltextzugriff (PDF)

First experience with direct factor Xa inhibition in patients with stable coronary disease: A pharmacokinetic and pharmacodynamic evaluation

Circulation (New York, N.Y.), 2002-05, Vol.105 (20), p.2385-2391

2002

Volltextzugriff (PDF)

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

Circulation (New York, N.Y.), 1995-04, Vol.91 (7), p.1929-1935

1995

Volltextzugriff (PDF)

Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency

Journal of thrombosis and haemostasis, 2005-11, Vol.3 (11), p.2437-2444

2005

Volltextzugriff (PDF)

Heritability of clotting factors and the revival of the prothrombotic state

The Lancet (British edition), 2002-02, Vol.359 (9307), p.638-639

2002

Volltextzugriff (PDF)

Initial experience with factor‐Xa inhibition in percutaneous coronary intervention: the XaNADU‐PCI Pilot

Journal of thrombosis and haemostasis, 2004-02, Vol.2 (2), p.234-241

2004

Volltextzugriff (PDF)

Genome scan of venous thrombosis in a pedigree with protein C deficiency

Journal of thrombosis and haemostasis, 2004-06, Vol.2 (6), p.868-873

2004

Volltextzugriff (PDF)

Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease

Thrombosis research, 2006, Vol.117 (4), p.439-446

2006

Volltextzugriff (PDF)

The association of vitamin K status with warfarin sensitivity at the onset of treatment

British journal of haematology, 2001-03, Vol.112 (3), p.572-577

2001

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(130)

Sprache

Englisch
(130)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(114)
Humans
(106)
Biological And Medical Sciences
(58)
Male
(56)
Medical Sciences
(54)
Female
(52)
Aged
(45)
Cardiovascular System & Cardiology
(43)
Hematology
(39)
Middle Aged
(37)
Adult
(33)
Peripheral Vascular Disease
(29)
Pharmacology. Drug Treatments
(19)
Cardiac & Cardiovascular Systems
(18)
Adolescent
(17)
Pedigree
(16)
Risk Factors
(16)
Blood. Blood Coagulation. Reticuloendothelial System
(15)
Pathology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

Inherited predisposition to thrombosis

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers: Evidence from Atomic Force Microscopy and Functional Assay

Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study

Laboratory methods and quality assurance in the Cardiovascular Health Study

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)

Markers of thrombin and platelet activity in patients with Atrial Fibrillation: Correlation with Stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III study

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C‐deficient family

The impact of venous thrombosis on quality of life

A review of the technical, diagnostic, and epidemiologic considerations for protein S assays

The Clinical Spectrum of Heterozygous Protein C Deficiency in a Large New England Kindred

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial

Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial

Vitamin K and oral anticoagulation: thought for food

Evaluating chronic venous disease with a new venous severity scoring system

First experience with direct factor Xa inhibition in patients with stable coronary disease: A pharmacokinetic and pharmacodynamic evaluation

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency

Heritability of clotting factors and the revival of the prothrombotic state

Initial experience with factor‐Xa inhibition in percutaneous coronary intervention: the XaNADU‐PCI Pilot

Genome scan of venous thrombosis in a pedigree with protein C deficiency

Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease

The association of vitamin K status with warfarin sensitivity at the onset of treatment

Suchergebnisse filtern